Latest News and Press Releases

Novoheart engineered the world’s first “human heart-in-a-jar” as part of its proprietary MyHeart™ platformNovoheart receives exclusive license from Harvard University to integrate pioneering...

VANCOUVER, British Columbia, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announced that it is changing its fiscal year-end to...

VANCOUVER, British Columbia, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announced today that Joseph Leung resigned as Chief...

Heart failure is a global pandemic with an estimated 64.3 million cases worldwide in 2017, costing over US$100B per yearDrug developers currently lack effective humanized models for preclinical...

VANCOUVER, British Columbia, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three months ended September 30, 2019....

VANCOUVER, British Columbia, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announces that it has granted incentive stock options to...

Novoheart seeks to revolutionize human heart tissue engineering for disease modeling and drug discovery Peer-reviewed publications feature results from the completion of two research contracts between...

VANCOUVER, British Columbia, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and twelve months ended June 30, 2019....

VANCOUVER, British Columbia, June 29, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) is pleased to announce that it has completed its...

VANCOUVER, British Columbia, June 17, 2019 (GLOBE NEWSWIRE) -- Novoheart Holdings Inc. (“Novoheart” or the “Company”) announced the appointment of Joseph Leung (“Joseph”) as its new Chief Financial...